Filing metadata

Accession number
0001638599-21-000270
Form type
Form 3
Filer
Spyre Therapeutics, Inc.
CIK
CIK 1636282
Filed
Feb 25, 2021
Reporting period
Feb 23, 2021
Description
Initial ownership

Explore SEC Filings Hub